Intended for healthcare professionals
The British Association of Dermatologist Biologics and Immunomodulators Register (BADBIR): an update

The original British Association of Dermatologists Biologic Interventions Register (BADBIR) was set up in 2007 to evaluate the long-term safety of biologic therapies for psoriasis1 . Data collected at baseline include current and previous treatments for psoriasis, disease severity, comorbid conditions and treatments, patientreported measures and lifestyle questions.

Dermatology in practice 2020; 26(2): 10–12
To continue reading this article, please sign in or register.